BIOMAT Database Logo BIOMAT Database Logo

HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGFβ activation. 2012

Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Institute of Pathology, University of Technology, Dresden, Germany.

A right amount of oxygen and nutrients is essential for a tumor to develop. The role of oxygen dependent pathways and their regulators is therefore of utmost importance although little is known about the detailed impact they can have. Recently we have shown that inhibition of the oxygen sensor PHD2 in tumor cells blocks tumor growth due to the anti-proliferative activity of TGFβ. In this study, we refined these results by comparing different shPHD2 sequences in depth in the early phase of tumor growth. Our findings also reveal an intriguing role for MMP2 and MT1MMP in these settings, as these activated proteases display an anti-proliferative characteristic through the activation of downstream TGFβ targets. In conclusion, PHD2 inhibition is essential for the regulation of the anti-tumoral activity in mouse tumor cells and might bring some new insight in our understanding of tumor growth inhibition.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D011393 Procollagen-Proline Dioxygenase A mixed-function oxygenase that catalyzes the hydroxylation of a prolyl-glycyl containing peptide, usually in PROTOCOLLAGEN, to a hydroxyprolylglycyl-containing-peptide. The enzyme utilizes molecular OXYGEN with a concomitant oxidative decarboxylation of 2-oxoglutarate to SUCCINATE. The enzyme occurs as a tetramer of two alpha and two beta subunits. The beta subunit of procollagen-proline dioxygenase is identical to the enzyme PROTEIN DISULFIDE-ISOMERASES. Protocollagen Prolyl Hydroxylase,Procollagen Prolyl 4-Hydroxylase,4-Hydroxylase, Procollagen Prolyl,Dioxygenase, Procollagen-Proline,Hydroxylase, Protocollagen Prolyl,Procollagen Proline Dioxygenase,Procollagen Prolyl 4 Hydroxylase,Prolyl 4-Hydroxylase, Procollagen,Prolyl Hydroxylase, Protocollagen
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype.
February 2007, Journal of cellular biochemistry,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Increased chemoresistance induced by inhibition of HIF-prolyl-hydroxylase domain enzymes.
January 2010, Cancer science,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury.
November 2018, Skeletal muscle,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression.
August 2010, Journal of molecular medicine (Berlin, Germany),
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
August 2003, Bioorganic & medicinal chemistry letters,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth.
April 2017, Annals of surgery,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury.
December 2018, Skeletal muscle,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
May 2011, Carcinogenesis,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Digoxin blocks tumor growth through HIF-1alpha inhibition.
January 2009, Current topics in medicinal chemistry,
Anne Klotzsche-von Ameln, and Antje Muschter, and Markus M Heimesaat, and Georg Breier, and Ben Wielockx
Inhibition of firefly luciferase activity by a HIF prolyl hydroxylase inhibitor.
September 2020, Journal of photochemistry and photobiology. B, Biology,
Copied contents to your clipboard!